HR Generalist M/F/d - Monheim am Rhein, Deutschland - Resolve BioSciences GmbH

Resolve BioSciences GmbH

Geprüftes Unternehmen

Monheim am Rhein, Deutschland

vor 3 Wochen

Geschrieben von:

Lena Wagner

beBee Recruiter

Beschreibung

Your mission:

Join our team as a Human Resources Generalist We are looking for a motivated professional to support our HR Team and ensure that our operations run smoothly and effectively, to deliver maximum value to the organization.

As key member of our team you will have the opportunity to participate in the creation of our compensation and benefits program policies, helping to shape our approach to employee rewards and incentives.

Responsibilities:

Act as an internal service provider for our employees, interns, and managers alike for HRrelevant topics as well as to ensure effective communication and resolution of employees concerns
Partner with HR team members to assist in the development and implementation of HR programs and policies, including performance management, employee relations, and HR compliance
Create overviews and statistics and manage Data maintenance in HR systems
Trusting and cooperative collaboration with the works council members
Create a compensation and benefits process including benefits policies and programs that are competitive and aligned with company goals and objectives

Your profile:

Bachelor's degree in Human Resources or related field
3+ years of experience in HR
First experience with Compensation & Benefit is a plus
Strong knowledge of federal and state employment laws and regulations
Excellent communication and interpersonal skills
Strong analytical and problemsolving skills
Ability to work independently and as part of a team
Enjoy being handson and building things
Enjoy working with multicultural, global teams

Why us?:

About us:

The Molecular Cartography Company

We are bringing the latest advances in German precision engineering to the biotechnology field.

Our Molecular Cartography platform has been well received by scientists through an early access program since 2016. We are now entering into an exciting phase of rapid growth and commercialization.